Keywords: idec, arthritis, drug, enters, phase, iii, pharmaceuticals

IDEC's Arthritis Drug Enters Phase III

Article | 23 December 1996

IDEC Pharmaceuticals has reported that partner SmithKline Beecham has started a Phase III trial of IDEC-CE9.1 (also known as SB210396), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in